Skip to main content
. 2022 Oct 11;306(2):e222040. doi: 10.1148/radiol.222040

Figure 1:

Images in a 50-year-old woman who presented for routine screening mammography and US 10 days after COVID-19 vaccination in her left arm. (A, B) Screening US scans demonstrate two prominent lymph nodes in the left axilla, with cortical thickening measuring up to 6 mm. (C) Targeted US scan obtained at 3-month follow-up demonstrates persistent lymphadenopathy. (D) US-guided core biopsy was performed, and pathologic examination yielded a benign reactive lymph node without evidence of malignancy.

Images in a 50-year-old woman who presented for routine screening mammography and US 10 days after COVID-19 vaccination in her left arm. (A, B) Screening US scans demonstrate two prominent lymph nodes in the left axilla, with cortical thickening measuring up to 6 mm. (C) Targeted US scan obtained at 3-month follow-up demonstrates persistent lymphadenopathy. (D) US-guided core biopsy was performed, and pathologic examination yielded a benign reactive lymph node without evidence of malignancy.